Arga Medtech raises €54.0M Series B round
27 February 2024· Epalinges, Switzerland· health, cardiovascular, b2b, software_hardware, deep_hardware
The funding will be used to advance the clinical development of the company's CSE Pulsed Field Ablation (PFA) system through an IDE study in the US and a CE Mark study in the EU, as well as to expand its US offices in San Diego.
Investors
LeadGilde Healthcare
Also participating
Zürcher KantonalbankAdvent Life SciencesEarlybird HealthUndisclosed strategic investorMedFocus
About Arga Medtech
Stage
Series B
Headquarters
Epalinges, Switzerland
Founded
2020
Team Size
21–50
Sectors
healthcardiovascularb2bsoftware_hardwaredeep_hardware
Source: https://argamedtech.com/news/arga-medtech-sa-closes-oversubscribed-series-b/